ID: ALA4585661

Max Phase: Preclinical

Molecular Formula: C23H18O4

Molecular Weight: 358.39

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COc1ccc(/C=C/c2cc(=O)oc3c2ccc2c(OC)cccc23)cc1

Standard InChI:  InChI=1S/C23H18O4/c1-25-17-10-7-15(8-11-17)6-9-16-14-22(24)27-23-18(16)12-13-19-20(23)4-3-5-21(19)26-2/h3-14H,1-2H3/b9-6+

Standard InChI Key:  RFXOQPIFVXKOIG-RMKNXTFCSA-N

Associated Targets(Human)

DNA ligase 1 262 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 358.39Molecular Weight (Monoisotopic): 358.1205AlogP: 5.13#Rotatable Bonds: 4
Polar Surface Area: 48.67Molecular Species: NEUTRALHBA: 4HBD: 0
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 4.50CX LogD: 4.50
Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.37Np Likeness Score: 0.25

References

1. Saquib M, Ansari MI, Johnson CR, Khatoon S, Kamil Hussain M, Coop A..  (2019)  Recent advances in the targeting of human DNA ligase I as a potential new strategy for cancer treatment.,  182  [PMID:31499361] [10.1016/j.ejmech.2019.111657]

Source